Perspectiva general

New Drug Product Development and Life Cycle Management

Drug development is an incredibly complex and risky endeavor, one that even experienced organizations will fail at more often than they succeed. This introductory course will help you understand how companies structure their efforts and utilize their resources to improve the odds of successful development and minimize the risks associated with shepherding a new drug candidate through the development process.

At the end of this course, you will be able to explain the phases, major work streams, key players, and interrelationships necessary to develop new drugs in the US and Europe and to expand the life cycle of in-line products. Interactive exercises will take you through the many decisions faced by an organization as they progress a new drug candidate through development and beyond.

Join us at the co-located Boston DIA Member Appreciation Reception and Kickoff for DIA 2018 on August 14, 5:30-7:45PM!

Lo que aprenderá

Drug development process
Candidate identification/preclinical testing
Phase 1
Phase 2
Phase 3 and regulatory review
Phase 4 and life cycle management

¿Quiénes deben asistir?

Professionals who wish to broaden their understanding of drug development in the pharmaceutical or biotechnology industry. This course should be of particular interest to those people who are moving from primarily functional positions into team membership roles or who are transitioning from other industries or from academia.

Objetivos de aprendizaje

At the conclusion of this activity, participants should be able to:

Explain how a desired drug product label dictates the components of the drug development plan
Identify the five major work streams that must be completed in any drug development program and describe their interactions
Describe the key functional area players and when they contribute to the six phases of drug development
Discuss the life cycle management process and how product line extensions are developed
Recognize the major differences between drug, biologic, and drug device development
Discuss the differences in the drug development process between the US and Europe
List where to find additional information on biologic and drug device development

Digital Learning Catalog

Download

¿Tiene una cuenta?